Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) announce the launch of the Trio-CIIC HAE Registry
LOUISVILLE, CO, May 12, 2022 – Enabled by the FDA guidance on the expanded use of real-world data, Trio Health has partnered with the CIIC to create the ‘first of its kind’ HAE (Hereditary Angioedema) Patient Registry. Trio Health’s real-world data platform rapidly converts structured and unstructured EMR data, in real time, including physician notes, […]
Consortium of Independent Immunology Clinics (CIIC) Welcomes Two New Members
Irving, TX / October 21, 2021 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization represented by a group of selected Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of two new members to its network. The addition of these providers and their clinic […]
Introducing the Creation of a Dynamic Rare Disease Patient Registry Platform
IRVING, TX, September 21, 2021 – Trio Health (Trio), in partnership with the Consortium of Independent Immunology Clinics (CIIC), has launched the creation of a dynamic rare disease patient registry platform to transform drug development for allergy, asthma, and immunology patients. This technology-driven and real-world data-based partnership will unite the power of the […]
Histogen and Amerimmune Report Publication on Emricasan in COVID-19
Histogen Inc. and its partner, Amerimmune, LLC, recently reported the publication of the potential utility of Emricasan in COVID-19 in Allergy, the official Journal of the European Academy of Allergy and Clinical Immunology. Amerimmune, in collaboration with Dr. Raavi Gupta from SUNY Downstate Medical Center and Dr. Lishomva Ndhlovu from Weill Cornell Medicine, demonstrated the […]
Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients
Yesterday, Histogen and Amerimmune, a research center and immunology laboratory owned by CIIC Member Dr. Oral Alpan, announced dosing the first patient in a Phase 1 study of Emricasan in mild symptomatic -COVID-19 patients to assess safety, tolerability, and preliminary efficacy. SUNY Downstate Medical Center in Brooklyn, New York, has been selected as the single […]
Clinical Cytometry
Today, the Consortium of Independent Immunology Clinics (CIIC) announces the publication of Validation of inducible basophil biomarkers: Time, temperature and transportation by Wiley Periodicals LLC on behalf of The Official Journal of the International Clinical Cytometry Society.
CIIC Welcomes Four New Members
Consortium of Independent Immunology Clinics (CIIC) Welcomes Four New Members January 30, 2021 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization represented by a group of selected Board Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of four new members to its network. […]
MedRxiv Pre-print: SARS-CoV-2
Today, the Consortium of Independent Immunology Clinics (CIIC) announced a recent pre-print in MedRxiv, co-authored by its member, Dr. Oral Alpan.
Journal of Hepatology Publication
Today, the Consortium of Independent Immunology Clinics (CIIC) announced a recent publication in the Journal of Hepatology, co-authored by its member, Dr. Oral Alpan.
Urgent Information to Our Patients
Introduction: In light of the current epidemic/pandemic of the coronavirus (COVID-19), here are some basic facts and instructions on how to deal with this new situation. This new coronavirus emanates from a family of viruses known to affect the respiratory system and cause respiratory infections. However, this particular coronavirus’s characteristic is unique for its high […]